Immunology Live

Online Events

Rheumatoid Arthritis

  • CME
    1.0

    Treat-to-Target Strategies in Rheumatoid Arthritis: Leveraging Novel and Emerging DMARDS to Achieve Goals

    Speakers:S. Louis Bridges Jr., MD, PhD, Professor of Medicine
    Maria I. Danila, MD, MSc, MSPH, Associate Professor of Medicine

    Duration: 60 minutes

    Presented on: December 1, 2016

Crohn's Disease

Psoriasis

Speakers

Rheumatoid Arthritis

  • S. Louis Bridges Jr., MD, PhD

    S. Louis Bridges Jr., MD, PhD

    S. Louis Bridges Jr., MD, PhD

    Professor of Medicine

    S. Louis Bridges, Jr., MD, PhD, is the Anna Lois Waters Endowed Professor of Medicine at the University of Alabama at Birmingham, director of the UAB Division of Clinical Immunology and Rheumatology, and director of the UAB Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center. His research focuses on identifying genetic influences on rheumatoid arthritis (RA) susceptibility and severity, particularly in African-Americans, and on biomarkers of treatment response in RA. He is chair of the American College of Rheumatology’s Committee on Research, and is a member of the Rheumatology Research Foundation’s Board of Directors and Scientific Advisory Council. Dr Bridges earned his medical degree from Louisiana State University School of Medicine in New Orleans.
  • Maria I. Danila, MD, MSc, MSPH

    Maria I. Danila, MD, MSc, MSPH

    Maria I. Danila, MD, MSc, MSPH

    Associate Professor of Medicine

    Maria I. Danila, MD, MSc, MSPH, is an associate professor of medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB) School of Medicine, and Medical Director, Rheumatology, at the Kirklin Clinic of UAB Hospital. Dr Danila is an investigative rheumatologist who holds a special interest in improving quality of care of patients with chronic conditions, such as arthritis and autoimmune diseases, by implementing evidence-based recommendations into routine practice and optimizing treatment adherence. Her K23 NIAMS-funded patient-oriented career development award is focused on understanding the relationship between the human genome, environment, and the development and outcomes of rheumatoid arthritis in African Americans.

Crohn's Disease

  • Joshua R. Korzenik, MD

    Joshua R. Korzenik, MD

    Joshua R. Korzenik, MD

    Director, Crohn's and Colitis Center

    Joshua R. Korzenik, MD, is a gastroenterologist on faculty at Harvard Medical School and the director of the Brigham and Women’s Hospital Crohn’s and Colitis Center in Boston, Massachusetts. He earned his MD from Albert Einstein College of Medicine, completed his internship and residency at Beth Israel Deaconess Medical Center, and his fellowship at Yale School of Medicine. Dr Korzenik is involved in care of patients with inflammatory bowel disease (IBD) and research in the field. He focuses on clinical and translational research aiming to improve understanding of the pathophysiology of the disease and the interaction with environmental factors, as well as the development of innovative therapies. He also focuses on developing new models of care to address psychosocial issues in IBD.

Psoriasis

  • Joseph F. Merola, MD,MMSc

    Joseph F. Merola, MD,MMSc

    Joseph F. Merola, MD,MMSc

    Assistant Professor of Dermatology

    Joseph F. Merola, MD, MMSc, is assistant professor at Harvard Medical School in Boston, whose clinical and research interests in immunology/autoimmunity are found at the intersection of dermatology and rheumatology. Dedicated to the improvement in the diagnosis and care of patients with psoriasis and psoriatic arthritis (PsA), his most recent work as the director of clinical trials in dermatology focuses on PsA screening tools, psoriasis outcome measures and burden of disease measurement in under recognized subsets of psoriasis, as well as ongoing efforts in the design and implementation of psoriasis/psoriatic arthritis clinical trials. Dr Merola earned his MD at New York University School of Medicine and his master’s degree in clinical translational research at Harvard Medical School.

All Speakers

  • S. Louis Bridges Jr., MD, PhD

    S. Louis Bridges Jr., MD, PhD

    S. Louis Bridges Jr., MD, PhD

    Professor of Medicine

    S. Louis Bridges, Jr., MD, PhD, is the Anna Lois Waters Endowed Professor of Medicine at the University of Alabama at Birmingham, director of the UAB Division of Clinical Immunology and Rheumatology, and director of the UAB Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center. His research focuses on identifying genetic influences on rheumatoid arthritis (RA) susceptibility and severity, particularly in African-Americans, and on biomarkers of treatment response in RA. He is chair of the American College of Rheumatology’s Committee on Research, and is a member of the Rheumatology Research Foundation’s Board of Directors and Scientific Advisory Council. Dr Bridges earned his medical degree from Louisiana State University School of Medicine in New Orleans.
  • Maria I. Danila, MD, MSc, MSPH

    Maria I. Danila, MD, MSc, MSPH

    Maria I. Danila, MD, MSc, MSPH

    Associate Professor of Medicine

    Maria I. Danila, MD, MSc, MSPH, is an associate professor of medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB) School of Medicine, and Medical Director, Rheumatology, at the Kirklin Clinic of UAB Hospital. Dr Danila is an investigative rheumatologist who holds a special interest in improving quality of care of patients with chronic conditions, such as arthritis and autoimmune diseases, by implementing evidence-based recommendations into routine practice and optimizing treatment adherence. Her K23 NIAMS-funded patient-oriented career development award is focused on understanding the relationship between the human genome, environment, and the development and outcomes of rheumatoid arthritis in African Americans.
  • Joshua R. Korzenik, MD

    Joshua R. Korzenik, MD

    Joshua R. Korzenik, MD

    Director, Crohn's and Colitis Center

    Joshua R. Korzenik, MD, is a gastroenterologist on faculty at Harvard Medical School and the director of the Brigham and Women’s Hospital Crohn’s and Colitis Center in Boston, Massachusetts. He earned his MD from Albert Einstein College of Medicine, completed his internship and residency at Beth Israel Deaconess Medical Center, and his fellowship at Yale School of Medicine. Dr Korzenik is involved in care of patients with inflammatory bowel disease (IBD) and research in the field. He focuses on clinical and translational research aiming to improve understanding of the pathophysiology of the disease and the interaction with environmental factors, as well as the development of innovative therapies. He also focuses on developing new models of care to address psychosocial issues in IBD.
  • Joseph F. Merola, MD,MMSc

    Joseph F. Merola, MD,MMSc

    Joseph F. Merola, MD,MMSc

    Assistant Professor of Dermatology

    Joseph F. Merola, MD, MMSc, is assistant professor at Harvard Medical School in Boston, whose clinical and research interests in immunology/autoimmunity are found at the intersection of dermatology and rheumatology. Dedicated to the improvement in the diagnosis and care of patients with psoriasis and psoriatic arthritis (PsA), his most recent work as the director of clinical trials in dermatology focuses on PsA screening tools, psoriasis outcome measures and burden of disease measurement in under recognized subsets of psoriasis, as well as ongoing efforts in the design and implementation of psoriasis/psoriatic arthritis clinical trials. Dr Merola earned his MD at New York University School of Medicine and his master’s degree in clinical translational research at Harvard Medical School.

Partners

Academic

  • logo-einstein

Publishers